These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21698392)

  • 41. The impact of the 2005 International Society of Urological Pathology (ISUP) consensus on Gleason grading in contemporary practice.
    Zareba P; Zhang J; Yilmaz A; Trpkov K
    Histopathology; 2009 Oct; 55(4):384-91. PubMed ID: 19817888
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.
    Srigley JR; Delahunt B; Samaratunga H; Billis A; Cheng L; Clouston D; Evans A; Furusato B; Kench J; Leite K; MacLennan G; Moch H; Pan CC; Rioux-Leclercq N; Ro J; Shanks J; Shen S; Tsuzuki T; Varma M; Wheeler T; Yaxley J; Egevad L
    Pathology; 2019 Aug; 51(5):463-473. PubMed ID: 31279442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis of Gleason pattern 5 prostate adenocarcinoma on core needle biopsy: an interobserver reproducibility study among urologic pathologists.
    Shah RB; Li J; Cheng L; Egevad L; Deng FM; Fine SW; Kunju LP; Melamed J; Mehra R; Osunkoya AO; Paner GP; Shen SS; Tsuzuki T; Trpkov K; Tian W; Yang XJ; Zhou M
    Am J Surg Pathol; 2015 Sep; 39(9):1242-9. PubMed ID: 25929349
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data.
    Delahunt B; Egevad L; Srigley JR; Steigler A; Murray JD; Atkinson C; Matthews J; Duchesne G; Spry NA; Christie D; Joseph D; Attia J; Denham JW
    Pathology; 2015 Oct; 47(6):520-5. PubMed ID: 26325671
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interobserver and intraobserver reproducibility in digital and routine microscopic assessment of prostate needle biopsies.
    Rodriguez-Urrego PA; Cronin AM; Al-Ahmadie HA; Gopalan A; Tickoo SK; Reuter VE; Fine SW
    Hum Pathol; 2011 Jan; 42(1):68-74. PubMed ID: 20970164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contemporary prostate biopsy reporting: insights from a survey of clinicians' use of pathology data.
    Varma M; Narahari K; Mason M; Oxley JD; Berney DM
    J Clin Pathol; 2018 Oct; 71(10):874-878. PubMed ID: 29720406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Interobserver reproducibility of Gleason grading in prostate biopsy samples].
    Bori R; Salamon F; Móczár C; Cserni G
    Orv Hetil; 2013 Aug; 154(31):1219-25. PubMed ID: 23895990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interobserver reproducibility of Gleason grading of prostatic adenocarcinoma among general pathologists.
    Singh RV; Agashe SR; Gosavi AV; Sulhyan KR
    Indian J Cancer; 2011; 48(4):488-95. PubMed ID: 22293266
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostate needle biopsy examination by means of virtual microscopy.
    Chargari C; Comperat E; Magné N; Védrine L; Houlgatte A; Egevad L; Camparo P
    Pathol Res Pract; 2011 Jun; 207(6):366-9. PubMed ID: 21570778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
    Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
    Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cribriform prostate cancer: Morphologic criteria enabling a diagnosis, based on survey of experts.
    Iczkowski KA; van Leenders GJLH; Tarima S; Wu R; Van der Kwast T; Berney DM; Evans AJ; Wheeler TM; Ro JY; Samaratunga H; Delahunt B; Srigley J; Varma M; Tsuzuki T; Egevad L
    Ann Diagn Pathol; 2021 Jun; 52():151733. PubMed ID: 33780691
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcome of Gleason 3 + 5 = 8 Prostate Cancer Diagnosed on Needle Biopsy: Prognostic Comparison with Gleason 4 + 4 = 8.
    Harding-Jackson N; Kryvenko ON; Whittington EE; Eastwood DC; Tjionas GA; Jorda M; Iczkowski KA
    J Urol; 2016 Oct; 196(4):1076-81. PubMed ID: 27265220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accuracy of gleason grading by practicing pathologists and the impact of education on improving agreement.
    Mikami Y; Manabe T; Epstein JI; Shiraishi T; Furusato M; Tsuzuki T; Matsuno Y; Sasano H
    Hum Pathol; 2003 Jul; 34(7):658-65. PubMed ID: 12874761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utility of Pathology Imagebase for standardisation of prostate cancer grading.
    Egevad L; Delahunt B; Berney DM; Bostwick DG; Cheville J; Comperat E; Evans AJ; Fine SW; Grignon DJ; Humphrey PA; Hörnblad J; Iczkowski KA; Kench JG; Kristiansen G; Leite KRM; Magi-Galluzzi C; McKenney JK; Oxley J; Pan CC; Samaratunga H; Srigley JR; Takahashi H; True LD; Tsuzuki T; van der Kwast T; Varma M; Zhou M; Clements M
    Histopathology; 2018 Jul; 73(1):8-18. PubMed ID: 29359484
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Impact of International Association of Urological Pathology Gleason scoring system on prostatic carcinoma grading: a preliminary analysis of 185 cases].
    Wang G; Shen D
    Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):677-9. PubMed ID: 25567594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gleason grading: past, present and future.
    Delahunt B; Miller RJ; Srigley JR; Evans AJ; Samaratunga H
    Histopathology; 2012 Jan; 60(1):75-86. PubMed ID: 22212079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Accuracy of Grading Gleason Score 7 Prostatic Adenocarcinoma on Needle Biopsy: Influence of Percent Pattern 4 and Other Histological Factors.
    Meliti A; Sadimin E; Diolombi M; Khani F; Epstein JI
    Prostate; 2017 May; 77(6):681-685. PubMed ID: 28155999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overall and worst gleason scores are equally good predictors of prostate cancer progression.
    Tolonen TT; Kujala PM; Tammela TL; Tuominen VJ; Isola JJ; Visakorpi T
    BMC Urol; 2011 Oct; 11():21. PubMed ID: 21978318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cases Having a Gleason Score 3+4=7 With <5% of Gleason Pattern 4 in Prostate Needle Biopsy Show Similar Failure-free Survival and Adverse Pathology Prevalence to Gleason Score 6 Cases in a Radical Prostatectomy Cohort.
    Sato S; Kimura T; Yorozu T; Onuma H; Iwatani K; Egawa S; Ikegami M; Takahashi H
    Am J Surg Pathol; 2019 Nov; 43(11):1560-1565. PubMed ID: 31436554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Minute foci of Gleason score 8-10 on prostatic needle biopsy: a morphologic analysis.
    Fine SW; Epstein JI
    Am J Surg Pathol; 2005 Jul; 29(7):962-8. PubMed ID: 15958863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.